These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance. Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488 [TBL] [Abstract][Full Text] [Related]
7. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286 [TBL] [Abstract][Full Text] [Related]
8. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase. Ding X; Gu Y; Jin M; Guo X; Xue S; Tan C; Huang J; Yang W; Xue M; Zhou Q; Wang W; Zhang Y Theranostics; 2020; 10(13):6048-6060. PubMed ID: 32483437 [No Abstract] [Full Text] [Related]
9. UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma. Yao J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Wang X; Dai J; Xu X World J Surg Oncol; 2022 May; 20(1):153. PubMed ID: 35546675 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin C-Terminal Hydrolase L1 regulates autophagy by inhibiting autophagosome formation through its deubiquitinating enzyme activity. Yan C; Huo H; Yang C; Zhang T; Chu Y; Liu Y Biochem Biophys Res Commun; 2018 Mar; 497(2):726-733. PubMed ID: 29462615 [TBL] [Abstract][Full Text] [Related]
11. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors. Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma. Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779 [TBL] [Abstract][Full Text] [Related]
13. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma. Tangri A; Lighty K; Loganathan J; Mesmar F; Podicheti R; Zhang C; Iwanicki M; Drapkin R; Nakshatri H; Mitra S Mol Cancer Res; 2021 Jul; 19(7):1168-1181. PubMed ID: 33753553 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation. Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842 [TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis. Liu S; González-Prieto R; Zhang M; Geurink PP; Kooij R; Iyengar PV; van Dinther M; Bos E; Zhang X; Le Dévédec SE; van de Water B; Koning RI; Zhu HJ; Mesker WE; Vertegaal ACO; Ovaa H; Zhang L; Martens JWM; Ten Dijke P Clin Cancer Res; 2020 Mar; 26(6):1460-1473. PubMed ID: 31857432 [TBL] [Abstract][Full Text] [Related]
16. UCHL1, a deubiquitinating enzyme, regulates lung endothelial cell permeability in vitro and in vivo. Mitra S; Epshtein Y; Sammani S; Quijada H; Chen W; Bandela M; Desai AA; Garcia JGN; Jacobson JR Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L497-L507. PubMed ID: 33438509 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells. Mao R; Tan X; Xiao Y; Wang X; Wei Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y Cancer Sci; 2020 Sep; 111(9):3174-3183. PubMed ID: 32539182 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitin carboxyl-terminal hydrolase L1 promotes hypoxia-inducible factor 1-dependent tumor cell malignancy in spheroid models. Li X; Hattori A; Takahashi S; Goto Y; Harada H; Kakeya H Cancer Sci; 2020 Jan; 111(1):239-252. PubMed ID: 31729096 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation. Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitin C-terminal hydrolase L1 (UCHL1), a double-edged sword in mammalian oocyte maturation and spermatogenesis. Yang D; Lu Q; Peng S; Hua J Cell Prolif; 2023 Feb; 56(2):e13347. PubMed ID: 36218038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]